Treatment of locally advanced non-small cell lung cancer
Approximately one third of non-small cell lung cancer (NSCLC) patients will present with locally advanced, stage III disease. With the use of pretreatment positron emission testing and mediastinal lymph node sampling, classifying stage III NSCLC has become more involved and treatment strategies have...
Gespeichert in:
| Veröffentlicht in: | Clinical advances in hematology & oncology 2009-07, Vol.7 (7), p.455-480 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 480 |
|---|---|
| container_issue | 7 |
| container_start_page | 455 |
| container_title | Clinical advances in hematology & oncology |
| container_volume | 7 |
| creator | Fidler, Mary Jo Kim, Anthony W Zusag, Thomas Bonomi, Philip |
| description | Approximately one third of non-small cell lung cancer (NSCLC) patients will present with locally advanced, stage III disease. With the use of pretreatment positron emission testing and mediastinal lymph node sampling, classifying stage III NSCLC has become more involved and treatment strategies have shifted from single modality thoracic radiation to combined chemoradiotherapy. This article reviews evidence-based strategies in the treatment of locally advanced NSCLC and presents new efforts for improving the poor prognosis of this disease by incorporating novel chemotherapy and biologic based regimens. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67600770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67600770</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-fb6ad3e8e51aa29b4f4ecb02605f140e707df2cc93dc3137d233d2a8d2a20e7f3</originalsourceid><addsrcrecordid>eNo1j0trwzAQhHVoadK0f6Ho1Jth9bBkH0voCwK5pGezllYlxZJdyy7k39eh6WF3YL5hmb1ia1FqVYCtYcVuc_4C0MJKc8NWorYgRKnWrDqMhFOkNPE-8K532HUnjv4HkyPPU5-KHBePO1pWN6dP7s5ovGPXAbtM9xfdsI-X58P2rdjtX9-3T7tiEFJPRWgNekUVlQJR1q0OmlwL0kAZhAayYH2QztXKOyWU9VIpL7FaRi40qA17_Ls7jP33THlq4jGfy2Cifs6NsQbAWliCD5fg3EbyzTAeI46n5v9X9Qu0tU7l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67600770</pqid></control><display><type>article</type><title>Treatment of locally advanced non-small cell lung cancer</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Fidler, Mary Jo ; Kim, Anthony W ; Zusag, Thomas ; Bonomi, Philip</creator><creatorcontrib>Fidler, Mary Jo ; Kim, Anthony W ; Zusag, Thomas ; Bonomi, Philip</creatorcontrib><description>Approximately one third of non-small cell lung cancer (NSCLC) patients will present with locally advanced, stage III disease. With the use of pretreatment positron emission testing and mediastinal lymph node sampling, classifying stage III NSCLC has become more involved and treatment strategies have shifted from single modality thoracic radiation to combined chemoradiotherapy. This article reviews evidence-based strategies in the treatment of locally advanced NSCLC and presents new efforts for improving the poor prognosis of this disease by incorporating novel chemotherapy and biologic based regimens.</description><identifier>ISSN: 1543-0790</identifier><identifier>PMID: 19701153</identifier><language>eng</language><publisher>United States</publisher><subject>Antineoplastic Combined Chemotherapy Protocols ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - radiotherapy ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Combined Modality Therapy ; Humans ; Lung Neoplasms - drug therapy ; Lung Neoplasms - pathology ; Lung Neoplasms - radiotherapy ; Neoplasm Staging ; Radiotherapy - methods</subject><ispartof>Clinical advances in hematology & oncology, 2009-07, Vol.7 (7), p.455-480</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19701153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fidler, Mary Jo</creatorcontrib><creatorcontrib>Kim, Anthony W</creatorcontrib><creatorcontrib>Zusag, Thomas</creatorcontrib><creatorcontrib>Bonomi, Philip</creatorcontrib><title>Treatment of locally advanced non-small cell lung cancer</title><title>Clinical advances in hematology & oncology</title><addtitle>Clin Adv Hematol Oncol</addtitle><description>Approximately one third of non-small cell lung cancer (NSCLC) patients will present with locally advanced, stage III disease. With the use of pretreatment positron emission testing and mediastinal lymph node sampling, classifying stage III NSCLC has become more involved and treatment strategies have shifted from single modality thoracic radiation to combined chemoradiotherapy. This article reviews evidence-based strategies in the treatment of locally advanced NSCLC and presents new efforts for improving the poor prognosis of this disease by incorporating novel chemotherapy and biologic based regimens.</description><subject>Antineoplastic Combined Chemotherapy Protocols</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - radiotherapy</subject><subject>Clinical Trials, Phase II as Topic</subject><subject>Clinical Trials, Phase III as Topic</subject><subject>Combined Modality Therapy</subject><subject>Humans</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - radiotherapy</subject><subject>Neoplasm Staging</subject><subject>Radiotherapy - methods</subject><issn>1543-0790</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0trwzAQhHVoadK0f6Ho1Jth9bBkH0voCwK5pGezllYlxZJdyy7k39eh6WF3YL5hmb1ia1FqVYCtYcVuc_4C0MJKc8NWorYgRKnWrDqMhFOkNPE-8K532HUnjv4HkyPPU5-KHBePO1pWN6dP7s5ovGPXAbtM9xfdsI-X58P2rdjtX9-3T7tiEFJPRWgNekUVlQJR1q0OmlwL0kAZhAayYH2QztXKOyWU9VIpL7FaRi40qA17_Ls7jP33THlq4jGfy2Cifs6NsQbAWliCD5fg3EbyzTAeI46n5v9X9Qu0tU7l</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Fidler, Mary Jo</creator><creator>Kim, Anthony W</creator><creator>Zusag, Thomas</creator><creator>Bonomi, Philip</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>Treatment of locally advanced non-small cell lung cancer</title><author>Fidler, Mary Jo ; Kim, Anthony W ; Zusag, Thomas ; Bonomi, Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-fb6ad3e8e51aa29b4f4ecb02605f140e707df2cc93dc3137d233d2a8d2a20e7f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - radiotherapy</topic><topic>Clinical Trials, Phase II as Topic</topic><topic>Clinical Trials, Phase III as Topic</topic><topic>Combined Modality Therapy</topic><topic>Humans</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - radiotherapy</topic><topic>Neoplasm Staging</topic><topic>Radiotherapy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fidler, Mary Jo</creatorcontrib><creatorcontrib>Kim, Anthony W</creatorcontrib><creatorcontrib>Zusag, Thomas</creatorcontrib><creatorcontrib>Bonomi, Philip</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical advances in hematology & oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fidler, Mary Jo</au><au>Kim, Anthony W</au><au>Zusag, Thomas</au><au>Bonomi, Philip</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of locally advanced non-small cell lung cancer</atitle><jtitle>Clinical advances in hematology & oncology</jtitle><addtitle>Clin Adv Hematol Oncol</addtitle><date>2009-07</date><risdate>2009</risdate><volume>7</volume><issue>7</issue><spage>455</spage><epage>480</epage><pages>455-480</pages><issn>1543-0790</issn><abstract>Approximately one third of non-small cell lung cancer (NSCLC) patients will present with locally advanced, stage III disease. With the use of pretreatment positron emission testing and mediastinal lymph node sampling, classifying stage III NSCLC has become more involved and treatment strategies have shifted from single modality thoracic radiation to combined chemoradiotherapy. This article reviews evidence-based strategies in the treatment of locally advanced NSCLC and presents new efforts for improving the poor prognosis of this disease by incorporating novel chemotherapy and biologic based regimens.</abstract><cop>United States</cop><pmid>19701153</pmid><tpages>26</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1543-0790 |
| ispartof | Clinical advances in hematology & oncology, 2009-07, Vol.7 (7), p.455-480 |
| issn | 1543-0790 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67600770 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Antineoplastic Combined Chemotherapy Protocols Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - radiotherapy Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Combined Modality Therapy Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Neoplasm Staging Radiotherapy - methods |
| title | Treatment of locally advanced non-small cell lung cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T23%3A58%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20locally%20advanced%20non-small%20cell%20lung%20cancer&rft.jtitle=Clinical%20advances%20in%20hematology%20&%20oncology&rft.au=Fidler,%20Mary%20Jo&rft.date=2009-07&rft.volume=7&rft.issue=7&rft.spage=455&rft.epage=480&rft.pages=455-480&rft.issn=1543-0790&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E67600770%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67600770&rft_id=info:pmid/19701153&rfr_iscdi=true |